miR-149-3p targeting TMPRSS4 regulates the sensitivity to cisplatin to inhibit the progression of lung cancer

Autor: Beibei Qin, Dongfang Tang, Mingzhi Zhang

Publikováno v: Biomolecules & Biomedicine (2024)

Lung cancer cells tend to develop resistance to cisplatin (DDP) during continuous chemotherapy, making it crucial to improve DDP sensitivity to enhance therapeutic outcomes. The levels of miR-149-3p in lung tissues and cells, as well as the biologica

Externí odkaz: https://doaj.org/article/1507e2417b5b49c5bb9397c4c5080703

Joint detection of miR‐149‐3p and hepcidin predicts the onset of obstructive sleep apnea syndrome in obese patients.

Autor: Xu, Lina¹ (AUTHOR), Gao, Haipeng¹ (AUTHOR), Wang, Weizhen¹ (AUTHOR) zhenwei_wang01@yeah.net

Publikováno v: Laryngoscope Investigative Otolaryngology. Oct2022, Vol. 7 Issue 5, p1643-1651. 9p.

Upregulation Of miR-149-3p Suppresses Spinal Chordoma Malignancy By Targeting Smad3.

Autor: Yao, Jie (AUTHOR), Wu, Xuejian (AUTHOR)

Publikováno v: OncoTargets & Therapy. Nov2019, Vol. 12, p9987-9997. 11p.

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.

Autor: Lu, Xiaoyuan^1,2 (AUTHOR), Jing, Li¹ (AUTHOR), Liu, Sicong³ (AUTHOR), Wang, Haihong¹ (AUTHOR), Chen, Buze^1,2 (AUTHOR)

Publikováno v: International Journal of Endocrinology. 6/8/2022, p1-15. 15p.

miR-149-3p targeting TMPRSS4 regulates the sensitivity to cisplatin to inhibit the progression of lung cancer.

Autor: Qin B; Department of Oncology, LuoYang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan Province, China., Tang D; Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Jing 'an District, Shanghai, China., Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Publikováno v: Biomolecules & biomedicine [Biomol Biomed] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.